“…23 Patch tests seem to be performed only rarely, that is, in only 16 of 39 cases (our cases 1 and 2; Supporting Information Table S1. 3,7,14,17,18,21,24 ) False-negative reactions may occur, for example, because of patch tests being performed too early, 22 as shown by the experience with rifampicin in our first case, and pyrazinamide in our second case. Thus, besides patch tests not frequently being performed, and, whenever they are performed, potentially resulting in false-negative test reactions, in part explained by the sometimes (too) short time interval between resolution of skin lesions and performance of these tests, they can still be of value.…”